跳至主要内容
临床试验/NCT05752383
NCT05752383招募中不适用

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2023年1月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Percentage of in-hospital mortality after cardiogenic shock

研究概览

简要总结

Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit.

This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock.

The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients hospitalized in ICU for cardiogenic shock
  • Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria

排除标准

  • Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock

结局指标

主要结局

Percentage of in-hospital mortality after cardiogenic shock

时间窗: 5 years

Vaso-inotropic score after cardiogenic shock

时间窗: 5 years

vasoactive-inotropic score (VIS) Maximal VIS (VISmax) is calculated using the highest doses of vasoactive and inotropic medications administered. VISmax categories: 0-5, \>5-15, \>15-30, \>30-45, and \>45 points.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验